Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New prosthetic foot lets amputees change heel height like shoes

NCT ID NCT07214493

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special prosthetic foot that can adjust heel height from 0 to 7 cm, allowing users to wear different shoes or go barefoot. Thirty adults with leg amputations will try both their usual foot and the adjustable foot to see if it improves how they feel about their appearance and their ability to take part in daily activities. The goal is to give amputees more freedom in choosing their clothing and footwear.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Taleo Adjust prosthetic foot with adjustable heel height
What this could lead to
If successful, this foot could help amputees wear different shoe heights comfortably, improving their confidence and social participation.
What could go wrong
This is a small early-stage trial with only 30 people, so results may not apply to everyone. The benefit may be small or not noticeable for some users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * Adult patient with a major lower limb amputation whose life project includes: * movement in buildings other than the home (ICF d4601), * movement outside the home and other buildings (ICF d4602), * and other specified activities related to movement in other various places (ICF d4608). * Patient who has been using an Enregy storage and Return (ESR) foot for at least 3 months * Patient who wishes to walk with shoes with different heel heights, and/or barefoot Exclusion Criteria: * Patient with a high impact level (e.g.: sport) * Patient with hip disarticulation or equivalent * Patient with an unstabilised residual limb and/or an unsuitable socket * Patient who cannot be fitted with a Taleo Adjust foot due to the technical characteristics of the product (user weight greater than 115kg; required foot size \<22 or \>28; mounting height less than 118 mm) * Patient whose usual foot has a heel height adjustment system * Patient unavailable for the duration of the study and/or unable to understand the instructions and/or answer questionnaires in French * Patient already participating in another study * Patient in an emergency situation or pregnant woman

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lower limb amputation above knee are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Cornouaille

    RECRUITING

    Concarneau, France

  • CHU Grenoble

    RECRUITING

    Échirolles, France

  • CRRF La Tourmaline

    RECRUITING

    Saint-Herblain, France

  • IRR Louis Pierquin

    RECRUITING

    Nancy, France

  • Institut Merle d'Aubigné

    RECRUITING

    Valenton, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.